Cecilia Yu is a Director in PwC’s Healthcare Deals practice. Her work is focused on advising Strategic and Private Equity buyers on M&A opportunities for value creation, integration and separation planning for transaction closes, and post-merger strategies to achieve integration goals. Her clients have included a variety of Fortune 500 companies in the pharmaceutical, provider and payer space as well as technology companies looking to expand their offerings and footprint within the healthcare industry. Prior to PwC, Cecilia was a consultant at Towers Watson, advising large employers on the strategy and performance of their health benefit plans.  ​

Cecilia received a BA from Wellesley College, an MBA from Columbia Business School, and an MPH from Harvard University. Originally from Hong Kong and Vancouver (Canada), Cecilia has been based in New York City since 2010. She is passionate about public health and the preservation of art, music and culture. ​